Some of the ARK Invest exchange-traded funds run by ETF star Cathie Wood made a huge purchase on Thursday. The funds bought over 415,000 shares altogether of Teladoc Health Inc. (NYSE: TDOC), as the prices of these ETFs bounced back on Thursday. Note that these funds are up handily in the past year.

Here’s a look at the purchases:

• ARK Fintech Innovation ETF (NYSEARCA: ARKF) bought 40,224 shares.
• ARK Genomic Revolution ETF (NYSEARCA: ARKG) purchased 78,216 shares.
• ARK Innovation ETF (NYSEARCA: ARKK) added 234,681 shares.
• ARK Next Generation Internet ETF (NYSEARCA: ARKW) bought 62,024 shares.

At Thursday’s closing price, this would have valued these purchases at roughly $51.5 million. Even though this is a small fraction of the total holdings, every little bit counts. These funds are up more than 14% in the past 52 weeks, with the exception of the Genomic Revolution ETF, which is actually down 6%.

Check out all of the ARK Invest buys for Thursday:

Fund	Ticker	Name	Shares
ARKF	KSPILI	KASPI.KZ	11,813
ARKF	TDOC	TELADOC HEALTH	40,224
ARKG	ALLO	ALLOGENE THERAPEUTICS	214,497
ARKG	BNR	BURNING ROCK BIOTECH	46,455
ARKG	TDOC	TELADOC HEALTH	78,216
ARKK	TDOC	TELADOC HEALTH	234,681
ARKK	SKLZ	SKILLZ	257,636
ARKK	NTLA	INTELLIA THERAPEUTICS	1,415
ARKK	MTLS	MATERIALISE	26,915
ARKK	BEAM	BEAM THERAPEUTICS	9,760
ARKQ	ACHR	ARCHER AVIATION	184,473
ARKQ	BLDE	BLADE AIR MOBILITY	227,784
ARKQ	VLD	VELO3D	438,062
ARKW	SKLZ	SKILLZ	494,859
ARKW	TDOC	TELADOC HEALTH	62,024
ARKX	MKFG	MARKFORGED	70,494

Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St., owner of 247wallst.com.

Get Our Free Investment Newsletter

I have read, and agree to the Terms of Use